Romark will soon begin Phase I clinical trials to test the anti-influenza virus activities of nitazoxanide, a medication currently used tin the treatment of diarrhea caused by giardia.

CCX168, an orally-administered small molecule designed to treat autoimmune diseases, is currently in clinical studies, ChemoCentryx, Inc announced.

ExpressDetect, a handheld diagnostic tool to detect the bacterial level in a chronic wounds ECI Biotech, has been awarded $511,472 as phase II grant in US.

Ring worm of the nail (onychomycosis) drug luliconazole may go on clinical trials this year: Topica

The new drug, sourced from blushwood shrubs, has a rapid action on solid tumours